In many cancers including lymphoma, colon, prostate and breast cancers, the remarkable propensity of malignant cells for high glycolysis activity frequently relies on the over-expression of hexokinase 1 and/or hexokinase 2 [43–47]. This evidence concerns the gene HK2 and breast carcinoma.